# Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex

> **NCT00000692** · PHASE1 · COMPLETED · sponsor: **G D Searle** · enrollment: 48 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Butyldeoxynojirimycin

## Key facts

- **NCT ID:** NCT00000692
- **Lead sponsor:** G D Searle
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000692, "Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00000692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*